Company Sector
Nucleic Acid Drugs
Nucleic Acid Drugs includes companies developing RNA, DNA, antisense, siRNA, mRNA, or related therapeutic approaches. This category is useful for tracking businesses whose core assets rely on sequence-based medicines rather than traditional small molecules or antibodies.
Why watch Nucleic Acid Drugs
This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.
Latest Nucleic Acid Drugs news
The latest feed items from companies currently grouped under Nucleic Acid Drugs.
- 01
- 02
- 03
- 04
- 05
- 06
- 07
- 08
- 09
- 10
- 11
- 12
- 13
- 14
- 15
- 16
BNTCBenitec Biopharma Releases Third Quarter 2026 Financial Results and Provides Operational Update
Source: Benitec Biopharma
- 17
- 18
- 19
BNTXBioNTech Announces New ADS Repurchase Program
Source: BioNTech
- 20
Companies in Nucleic Acid Drugs
12 companies tagged with Nucleic Acid Drugs.
Frequently Asked Questions
What does the Nucleic Acid Drugs sector include?
Nucleic Acid Drugs includes companies developing RNA, DNA, antisense, siRNA, mRNA, or related therapeutic approaches. This category is useful for tracking businesses whose core assets rely on sequence-based medicines rather than traditional small molecules or antibodies.
How many companies are currently tagged with Nucleic Acid Drugs?
12 companies are currently grouped under Nucleic Acid Drugs on BioPharmSignal.
Which companies are most visible in the Nucleic Acid Drugs group right now?
ALNY, ABUS, BNTC, BPTH are among the companies currently shown on this sector page.
How can I watch news for Nucleic Acid Drugs?
Use the Watch button on this page to subscribe to Nucleic Acid Drugs headlines and related company updates through your BioPharmSignal saved filters.
What kinds of updates usually appear for Nucleic Acid Drugs?
The livefeed typically surfaces company press releases, clinical readouts, FDA and regulatory updates, partnerships, financings, and commercialization developments tied to companies in Nucleic Acid Drugs.